KRAS-mutated non-small cell lung cancer: new therapy strategies

QR Code

KRAS-mutated non-small cell lung cancer: new therapy strategies

Lung cancer remains one of the most dangerous and most common cancers, requiring constant improvement of diagnostic and treatment methods. The genetic heterogeneity of lung cancer forces us to search for new therapeutic targets in an attempt to achieve greater effectiveness for certain groups of pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. K. Laktionov, K. A. Sarantseva, L. A. Nelyubina, S. V. Gamayunov, E. A. Kolesnikova, M. G. Gordiev
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2024-05-01
Series:	Сибирский онкологический журнал
Subjects:	nsclc molecular genetic testing kras kras g12c sotorasib ngs
Online Access:	https://www.siboncoj.ru/jour/article/view/3039
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma
by: Prasanna Srinivasan Ramalingam, et al.
Published: (2025-07-01)

Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer
by: K. K. Laktionov, et al.
Published: (2022-03-01)

KRAS Mutations as Predictive Biomarkers for First-Line Immune Checkpoint Inhibitor Monotherapy in Advanced NSCLC: A Systematic Review and Meta-Analysis
by: Filip Marković, et al.
Published: (2025-06-01)

Case report of metastatic colorectal cancer associated with <i>KRAS</i> A146V and A59G mutations
by: O. I. Kit, et al.
Published: (2023-07-01)

Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01)

The role of KRAS and NRAS mutation detection in determining the therapy strategy for colorectal cancer
by: A. N. Toropovskiy, et al.
Published: (2022-11-01)

STUDY OF THE RELATIONSHIP BETWEEN KRAS GENE MUTATIONS AND GENDER, AGE AND RACE IN COLORECTAL CANCER PATIENTS RESIDING IN THE REPUBLIC OF KAZAKHSTAN
by: D. R. Kaydarova, et al.
Published: (2020-03-01)

The association between detection the presence of KRAS mutations in tumors and circulating tumor cells from patients with colorectal cancer
by: O. I. Kit, et al.
Published: (2016-02-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

Study on the mechanism of KRAS R68G secondary mutation-induced resistance to KRASG12D-targeted inhibitor MRTX1133
by: WANG Gaoming, et al.
Published: (2025-06-01)

ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
by: E. E. Pisareva, et al.
Published: (2016-07-01)

Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinoma
by: B. N. Gurmikov, et al.
Published: (2020-04-01)

Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion
by: Walter V. Velasco, et al.
Published: (2025-09-01)

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study
by: Christine Nitschke, et al.
Published: (2025-07-01)

SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells
by: Lei Jiang, et al.
Published: (2019-12-01)

An Advanced IVB Lung Adenocarcinoma Patient With KRAS Mutations, Benefited From Camrelizumab Combined With Anti‐Angiogenic Agents for Therapy: A Case Report
by: Li Wang, et al.
Published: (2025-06-01)

Site‐Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer
by: Fumihiro Yoshimura, et al.
Published: (2025-07-01)

Prediction of KRAS gene mutations in colorectal cancer using a CT-based radiomic model
by: Wenjing Wang, et al.
Published: (2025-05-01)

INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01)

Targeting KRAS Sensitizes Ferroptosis by Coordinately Regulating the TCA Cycle and Nrf2‐SLC7A11‐GPX4 Signaling in Hepatocellular Carcinoma
by: Jiaxin Zhang, et al.
Published: (2025-06-01)

Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01)

Lack of Association between LCS6 Variant in KRAS Gene with the Occurrence of Breast Tumors in Iraqi Women
by: Al-Haddad et al.
Published: (2020-05-01)

SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO
by: M. N. Yurova, et al.
Published: (2018-07-01)

HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective phase Ib/II trial
by: Qingqing Leng, et al.
Published: (2025-07-01)

Diagnostic accuracy evaluation of individual or combinational fecal immunochemical test, M3 gene, KRAS mutation and tumor methylation burden in colorectal carcinoma
by: Junyue Xu, et al.
Published: (2025-07-01)

Efek Mutasi K-RAS pada Kanker Kolorektal terhadap Terapi Antibodi Monoklonal anti EGFR
by: Farid Sastra Nagara, et al.
Published: (2008-12-01)

Detection of gene mutations in genome “hot” spots: “hairpin” amplicons in DNA melting analysis
by: V. N. Kondratova, et al.
Published: (2017-04-01)

Evaluation of BRAF and KRAS Gene Expression in Nasal Polyposis
by: Gül Özbilen Acar, et al.
Published: (2025-06-01)

Medullary carcinoma of the pancreas radiologically followed up as a cystic lesion for 9 years: a case report and review of the literature
by: Akikazu Yago, et al.
Published: (2018-07-01)

Target liquid biopsy using “enriched” polymerase chain reaction and DNA melting analysis
by: I. V. Botezatu, et al.
Published: (2018-05-01)

REQUIREMENTS FOR EFFICIENT PCR CLAMPING BY LOCKED NUCLEIC ACID OLIGONUCLEOTIES FOR SIMPLE AND SENSITIVE DETECTION OF SOMATIC MUTATIONS
by: V. A. Shamanin, et al.
Published: (2018-09-01)

The recurrence with isolated intra-abdominal lymph node in patients with colorectal cancer: A study of the Turkish Descriptive Oncological Researches Group (intra-abdominal lymph node and colon cancer)
by: Ozgur Tanriverdi, et al.
Published: (2016-08-01)

Search for Mutations Connected With Non‐Response to Anti‐EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary Tumours
by: Martina Čarnogurská, et al.
Published: (2025-05-01)

Eosinophilic Cells as a Distinct Morphological Feature in <i>BRAF<sup>V600E</sup></i>-Mutated Ovarian Serous Borderline Tumors
by: Alina Badlaeva, et al.
Published: (2025-06-01)

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
by: Zheng Wu, et al.
Published: (2025-01-01)

Liver metastasis composed of pure squamous cell carcinoma component from pancreatic pure ductal adenocarcinoma: a case report
by: Yohei Mano, et al.
Published: (2023-09-01)

Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01)

Mucinous Cystic Neoplasms in Male Patients: Histopathological and Molecular Diagnoses
by: Lara Malaspina, et al.
Published: (2025-06-01)

Difference in serum cytokines between metastatic colorectal cancer patients with mutant and wild type RAS in response to targeted treatment with monoclonal antibodies
by: E. Yu. Zlatnik, et al.
Published: (2024-07-01)

MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T
by: A. O. Ivantsov, et al.
Published: (2016-04-01)